{"id":"https://openalex.org/W4381415404","doi":"https://doi.org/10.1039/d3dt01623d","title":"Models of the putative antimony( v )\u2013diolate motifs in antileishmanial pentavalent antimonial drugs","display_name":"Models of the putative antimony( v )\u2013diolate motifs in antileishmanial pentavalent antimonial drugs","publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W4381415404","doi":"https://doi.org/10.1039/d3dt01623d","pmid":"https://pubmed.ncbi.nlm.nih.gov/37357833"},"language":"en","primary_location":{"id":"doi:10.1039/d3dt01623d","doi":"https://doi.org/10.1039/d3dt01623d","is_oa":false,"landing_page_url":"https://doi.org/10.1039/d3dt01623d","pdf_url":null,"source":{"id":"https://openalex.org/S166159787","display_name":"Dalton Transactions","issn_l":"1477-9226","issn":["1477-9226","1477-9234"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dalton Transactions","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://escholarship.org/content/qt1dh2s26j/qt1dh2s26j.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002964227","display_name":"Brent Lindquist\u2010Kleissler","orcid":"https://orcid.org/0000-0002-6546-918X","observed_orcids":["https://orcid.org/0000-0002-6546-918X"]},"institutions":[{"id":"https://openalex.org/I185103710","display_name":"University of California, Santa Cruz","ror":"https://ror.org/03s65by71","country_code":"US","type":"education","lineage":["https://openalex.org/I185103710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brent Lindquist-Kleissler","raw_affiliation_strings":["Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, USA"],"raw_orcid":"https://orcid.org/0000-0002-6546-918X","affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, USA","institution_ids":["https://openalex.org/I185103710"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090805594","display_name":"Timothy C. Johnstone","orcid":"https://orcid.org/0000-0003-3615-4530","observed_orcids":["https://orcid.org/0000-0003-3615-4530"]},"institutions":[{"id":"https://openalex.org/I185103710","display_name":"University of California, Santa Cruz","ror":"https://ror.org/03s65by71","country_code":"US","type":"education","lineage":["https://openalex.org/I185103710"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Timothy C. Johnstone","raw_affiliation_strings":["Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, USA"],"raw_orcid":"https://orcid.org/0000-0003-3615-4530","affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, USA","institution_ids":["https://openalex.org/I185103710"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090805594"],"corresponding_institution_ids":["https://openalex.org/I185103710"],"apc_list":null,"apc_paid":null,"fwci":0.746,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.62908138,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"52","issue":"27","first_page":"9229","last_page":"9237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10807","display_name":"Synthesis and characterization of novel inorganic/organometallic compounds","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10807","display_name":"Synthesis and characterization of novel inorganic/organometallic compounds","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12458","display_name":"Organometallic Compounds Synthesis and Characterization","score":0.44040000438690186,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11441","display_name":"Organoboron and organosilicon chemistry","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pentavalent-antimonials","display_name":"pentavalent antimonials","score":0.9300000071525574},{"id":"https://openalex.org/keywords/antimony-v-complexes","display_name":"antimony(V) complexes","score":0.6019999980926514},{"id":"https://openalex.org/keywords/leishmaniasis","display_name":"leishmaniasis","score":0.9039999842643738},{"id":"https://openalex.org/keywords/antileishmanial-agents","display_name":"antileishmanial agents","score":0.9309999942779541},{"id":"https://openalex.org/keywords/molecular-structure-elucidation","display_name":"chemical structure elucidation","score":0.6850000023841858},{"id":"https://openalex.org/keywords/stereochemistry","display_name":"stereochemistry","score":0.6570000052452087},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C121349320","wikidata":"https://www.wikidata.org/wiki/Q285851","display_name":"Vicinal","level":2,"score":0.6634638905525208},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5962366461753845},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5076810121536255},{"id":"https://openalex.org/C66974803","wikidata":"https://www.wikidata.org/wiki/Q10359898","display_name":"Nuclear magnetic resonance spectroscopy","level":2,"score":0.46735385060310364},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.42544716596603394},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.42061400413513184},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.41879695653915405},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1746889352798462},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12982597947120667}],"mesh":[{"descriptor_ui":"D000965","descriptor_name":"Antimony","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000981","descriptor_name":"Antiprotozoal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000981","descriptor_name":"Antiprotozoal Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1039/d3dt01623d","doi":"https://doi.org/10.1039/d3dt01623d","is_oa":false,"landing_page_url":"https://doi.org/10.1039/d3dt01623d","pdf_url":null,"source":{"id":"https://openalex.org/S166159787","display_name":"Dalton Transactions","issn_l":"1477-9226","issn":["1477-9226","1477-9234"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dalton Transactions","raw_type":"journal-article"},{"id":"pmid:37357833","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37357833","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dalton transactions (Cambridge, England : 2003)","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt1dh2s26j","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/1dh2s26j","pdf_url":"https://escholarship.org/content/qt1dh2s26j/qt1dh2s26j.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dalton Transactions, vol 52, iss 27","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:escholarship.org:ark:/13030/qt1dh2s26j","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/1dh2s26j","pdf_url":"https://escholarship.org/content/qt1dh2s26j/qt1dh2s26j.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dalton Transactions, vol 52, iss 27","raw_type":"article"},"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G7213649444","display_name":"MRI: Acquisition of a Single-Crystal X-Ray Diffractometer","funder_award_id":"2018501","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320311968","display_name":"Hellman Foundation","ror":"https://ror.org/02g98ya79"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4381415404.pdf","grobid_xml":"https://content.openalex.org/works/W4381415404.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1523586839","https://openalex.org/W1969360633","https://openalex.org/W1989306682","https://openalex.org/W2008441025","https://openalex.org/W2015614693","https://openalex.org/W2027683710","https://openalex.org/W2028517817","https://openalex.org/W2034729442","https://openalex.org/W2045075387","https://openalex.org/W2060443743","https://openalex.org/W2069837000","https://openalex.org/W2084796589","https://openalex.org/W2089836448","https://openalex.org/W2090378740","https://openalex.org/W2105249240","https://openalex.org/W2128555893","https://openalex.org/W2132454074","https://openalex.org/W2242774512","https://openalex.org/W2765751294","https://openalex.org/W2909197699","https://openalex.org/W3164835194","https://openalex.org/W4253806278","https://openalex.org/W4313441652"],"related_works":["https://openalex.org/W7038597280","https://openalex.org/W2503665197","https://openalex.org/W2790494845","https://openalex.org/W2527728709","https://openalex.org/W2041705537","https://openalex.org/W2753384651","https://openalex.org/W2793025020","https://openalex.org/W1989306682","https://openalex.org/W2098091044","https://openalex.org/W1994025710"],"abstract_inverted_index":{"The":[0,141],"structures":[1,44,68,104,156],"of":[2,34,69,76,102,105,110,113,135,138,157],"the":[3,12,67,70,80,103,111,114,117,123,128,136,139,155,158],"pentavalent":[4,71,159],"antimonials,":[5],"small-molecule":[6],"Sb-containing":[7],"drugs":[8,29],"used":[9],"to":[10],"treat":[11],"neglected":[13],"tropical":[14],"disease":[15],"leishmaniasis,":[16],"remain":[17],"unknown":[18],"despite":[19],"their":[20],"widespread":[21],"use":[22],"for":[23,153],"over":[24],"half":[25],"a":[26,39,47,53,62,74,85,133,151],"century.":[27],"These":[28],"are":[30,122],"prepared":[31],"by":[32,84],"combination":[33],"an":[35,58],"Sb(V)":[36,59,118],"precursor":[37],"and":[38,42,92,96,109],"sugar":[40],"derivative":[41],"proposed":[43],"frequently":[45],"invoke":[46],"cyclic":[48,77],"stiborane":[49],"motif":[50,88],"in":[51,127],"which":[52],"vicinal":[54,86],"diolate":[55,87,115],"ligand":[56],"chelates":[57],"center.":[60,119],"As":[61],"step":[63],"towards":[64],"better":[65],"understanding":[66],"antimonial":[72,160],"drugs,":[73],"series":[75],"organostiboranes":[78],"spanning":[79],"stereochemical":[81],"space":[82],"afforded":[83],"has":[89],"been":[90],"synthesized":[91],"characterized.":[93],"X-ray":[94],"crystallography":[95],"NMR":[97,129],"spectroscopy":[98],"provide":[99,150],"unambiguous":[100],"characterization":[101],"these":[106,146],"model":[107,147],"compounds":[108,148],"interaction":[112],"with":[116,145],"Particularly":[120],"notable":[121],"systematic":[124],"trends":[125],"observed":[126],"spectroscopic":[130,142],"signals":[131],"as":[132],"function":[134],"stereochemistry":[137],"diolate.":[140],"signatures":[143],"identified":[144],"will":[149],"framework":[152],"elucidating":[154],"drugs.":[161]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-06-21T00:00:00"}